Skip to main navigation Presentations June 23, 2020 SPIRIT 1 Phase 3 Endometriosis Study Results June 1, 2020 HERO Phase 3 Advanced Prostate Cancer Additional Efficacy and Cardiovascular Safety Data April 22, 2020 SPIRIT 2 Phase 3 Endometriosis Study and Ovulation Inhibition Study March 19, 2020 Cowen 40th Annual Health Care Conference Presentation January 15, 2020 J.P. Morgan Healthcare Conference Presentation November 19, 2019 HERO Phase 3 Advanced Prostate Cancer Study Results July 23, 2019 LIBERTY 2 Phase 3 Uterine Fibroid and Bioequivalence Study Results May 14, 2019 LIBERTY 1 Phase 3 Uterine Fibroid Study Results TOOLKIT Print Page RSS Feeds Email Alerts Contact Search © 2021 Myovant Sciences GmbH. All rights reserved. Terms of Use Privacy Policy Cookie Policy Compliance & Prescriber Information

Skip to main navigation Analyst Coverage Brian Skorney Baird Phil Nadeau Cowen Gavin Clark-Gartner Evercore ISI Madhu Kumar Goldman Sachs Eric Joseph JP Morgan Roanna Ruiz SVB Leerink Myovant Sciences Ltd. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Myovant Sciences Ltd.'s performance made by these analysts are theirs alone, and do not represent opinions, forecasts or predictions of Myovant Sciences Ltd. or its management. Myovant Sciences Ltd. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. TOOLKIT Print Page RSS Feeds Email Alerts Contact Search © 2021 Myovant Sciences GmbH. All rights reserved. Terms of Use Privacy Policy Cookie Policy Compliance & Prescriber Information